title: Mn-DPDP enhanced MRI in experimental bile duct obstruction.
abstract: To assess both the effect of Mn-DPDP as a hepatobiliary-specific contrast agent in bile duct obstruction and the relative role of liver and kidney in the elimination of this agent from the body, an animal experiment was set up. Twelve rats were used and divided into three groups. In group 1 the common bile duct was ligated, in group 2 bile duct ligation was limited to one lobe, and group 3 served as control. Magnetic resonance T1-weighted SE images were obtained before and after the injection of 25 mumol/kg of Mn-DPDP during the first 2 h and at day 1, 2, 3, 4, and, in some animals, up to 21 days. In normal rats the absolute enhancement signal-to-noise ratio (S/N) versus time plots obtained from the liver after Mn-DPDP injection returned to precontrast values within 24 h. In the group with common bile duct ligation, important liver enhancement persisted up to 21 days. In the group with selective obstruction, liver intensity normalized after 3 days. The S/N plots from spleen, renal cortex, and obstructed liver lobe showed similarities in time course. The present data indicate that Mn elimination is strongly impaired in the presence of bile duct obstruction. Renal glomerular filtration is ineffective in eliminating Mn from the body. The persisting splenic and renal cortical enhancement suggests that free Mn or some Mn-DPDP metabolite either is strongly bound to plasma proteins and acts as a blood pooling agent and/or is uptaken by the splenic or renal parenchyma.
authors.affiliation: Department of Radiology, University Hospitals K.U. Leuven, Belgium.
authors.forename: G
authors.initials: G
authors.lastname: Marchal
authors.forename: Y
authors.initials: Y
authors.lastname: Ni
authors.forename: X
authors.initials: X
authors.lastname: Zhang
authors.forename: J
authors.initials: J
authors.lastname: Yu
authors.forename: K P
authors.initials: KP
authors.lastname: Lodemann
authors.forename: A L
authors.initials: AL
authors.lastname: Baert
mesh_terms: D000818:Animals; D001653:Bile Ducts, Intrahepatic / Q000473:pathology; D002779:Cholestasis / Q000175:diagnosis* / Q000473:pathology; D003287:Contrast Media; D004492:Edetic Acid / Q000031:analogs & derivatives*; D005347:Fibroblasts / Q000473:pathology; D006965:Hyperplasia; D007089:Image Enhancement / Q000379:methods; D007672:Kidney Cortex / Q000473:pathology; D008099:Liver / Q000473:pathology; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008345:Manganese; D011732:Pyridoxal Phosphate / Q000031:analogs & derivatives*; D051381:Rats; D017208:Rats, Wistar; D013154:Spleen / Q000473:pathology
chemical_list: D003287:Contrast Media; D008345:Manganese; D011732:Pyridoxal Phosphate; D004492:Edetic Acid; C060076:N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid